Mds Podcast

As part of the MDS Congress 2019 Special Issue, Dr. Matarazzo interviews Dr. Respondek about atypical parkinsonisms, focusing on the MDS activities to advance in the knowledge and management of these diseases and facilitate clinical trials.

Dr. Schaefer discusses with Dr. Kamel the role of botulinum toxin in the treatment of refractory upper limb tremor, and his center's tailored approach to provide relief for these patients.

As part of the MDS Congress 2019 Special Issue, Dr. Schaefer interviews Dr. Strafella about the emerging research in neuroimaging in movement disorders and plans to establish a centralized database for neuroimaging in atypical parkinsonisms.

As part of the MDS Congress 2019 Special Issue, Dr. Schaefer interviews Dr. Jinnah about notable research in dystonia and activities of the MDS Dystonia Study Group.

As part of the MDS Congress 2019 Special Issue, Dr. Schaefer and Dr. Tabrizi discuss the evolving research in disease-modifying therapies for Huntington's Disease, and what may come next.

As part of the MDS Congress 2019 Special Issue, Dr. Schaefer interviews Dr. Postuma about all of the educational offerings through the MDS, as well as new projects of the MDS Education Committee.

Did you miss the MDS Congress in Nice, or do you just want an overview of highlights from the Congress as well as a look forward at new ventures? Dr. Schaefer introduces the MDS Congress 2019 special issue, which features interviews with experts in various fields of movement disorders at the MDS Congress 2019. In this first issue, Dr. Schaefer interviews Dr. LaFaver about notable research in functional movement disorders, activities of the MDS Functional Movement Disorders Study Group, and more.

In this interview with Dr. Jabbari we highlight the results of his study on the definition and genetic and neuropathological characteristics of early onset progressive supranuclear palsy. The full study is available on the September 2019 issue of the Movement Disorders Journal.

Dr. Farwa Ali discusses with Dr. Schaefer the results of her study on the use of the MDS criteria for PSP with the MAX rules and their clinical implications, as well as the challenges of the phenotype variability of this disease in clinical practice and research.

Dr. Bergsland discusses with Dr. Matarazzo the results of the paper he recently published in the Movement Disorder Journal on longitudinal iron imaging in the substantia nigra in PD and in its different regions.

Benjamin Deck discusses with Dr. Schaefer the article he recently published in the Movement Disorders Clinical Practice on the patient vs. care partner assessment of cognition in Parkinson's disease.

Dr. Chang shares the results of 4-year follow-up of MR-guided focused ultrasound thalamotomy in essential tremor.

Dr. Ruth Schneider discusses with Dr. Sara Schaefer about the article she recently published in the Movement Disorders Clinical Practice that investigates the outcomes of early vs delayed start of dopaminergic medication in Parkinson's disease.

Dr. Ray Chaudhuri discusses with Dr. Michele Matarazzo his article on the differences between subthalamic nucleus DBS, intrajejunal levodopa and apomorphine infusion in Parkinson's, published in the March 2019 issue of the Movement Disorders Journal.

Dr. Mered Parnes discusses with Dr. Sara Schaefer his article on benign hereditary chorea recently published in the January 2019 issue of the Movement Disorders Clinical Practice.

Dr. Nikolaos Scarmeas discusses with Dr. Michele Matarazzo the results of his article about the impact of the Mediterranean diet on the risk of Parkinson's disease, published in the January 2019 issue of the Movement Disorders Journal. (January 2019).